These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36919284)

  • 21. FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis.
    Jiménez Morales A; Maldonado-Montoro M; Martínez de la Plata JE; Pérez Ramírez C; Daddaoua A; Alarcón Payer C; Expósito Ruiz M; García Collado C
    J Clin Pharmacol; 2019 Apr; 59(4):517-531. PubMed ID: 30457672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients.
    Chen JY; Wang CM; Chang SW; Cheng CH; Wu YJ; Lin JC; Yang B; Ho HH; Wu J
    Arthritis Rheumatol; 2014 Nov; 66(11):3113-21. PubMed ID: 25154742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the association of Fc gamma receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A.
    Kyogoku C; Tsuchiya N; Matsuta K; Tokunaga K
    Genes Immun; 2002 Dec; 3(8):488-93. PubMed ID: 12486608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome.
    Rossi GM; Bonatti F; Adorni A; Alberici F; Bodria M; Bonanni A; Ghiggeri GM; Martorana D; Vaglio A
    Immunol Lett; 2018 Jan; 193():11-13. PubMed ID: 29155175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.
    Cartron G; Ohresser M; Salles G; Solal-Céligny P; Colombat P; Watier H
    Ann Oncol; 2008 Aug; 19(8):1485-1487. PubMed ID: 18408222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes.
    Franke L; el Bannoudi H; Jansen DT; Kok K; Trynka G; Diogo D; Swertz M; Fransen K; Knevel R; Gutierrez-Achury J; Ärlestig L; Greenberg JD; Kremer J; Pappas DA; Kanterakis A; Weersma RK; van der Helm-van Mil AH; Guryev V; Rantapää-Dahlqvist S; Gregersen PK; Plenge RM; Wijmenga C; Huizinga TW; Ioan-Facsinay A; Toes RE; Zhernakova A
    Eur J Hum Genet; 2016 Feb; 24(2):263-70. PubMed ID: 25966632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FcGR genetic polymorphisms and the response to adalimumab in patients with rheumatoid arthritis.
    Dávila-Fajardo CL; van der Straaten T; Baak-Pablo R; Medarde Caballero C; Cabeza Barrera J; Huizinga TW; Guchelaar HJ; Swen JJ
    Pharmacogenomics; 2015; 16(4):373-81. PubMed ID: 25823785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.
    Meletiadis J; Walsh TJ; Choi EH; Pappas PG; Ennis D; Douglas J; Pankey GA; Larsen RA; Hamill RJ; Chanock S
    Med Mycol; 2007 Sep; 45(6):513-8. PubMed ID: 17710620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis.
    Lee YH; Ji JD; Song GG
    J Rheumatol; 2008 Nov; 35(11):2129-35. PubMed ID: 18843786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NA1/NA2 heterozygote of Fcgr3b is a risk factor for progression of IgA nephropathy in Chinese.
    Xu G; He Q; Shou Z; Wang H; Zhang X; Wang Y; Chen Y; Chen J
    J Clin Lab Anal; 2007; 21(5):298-302. PubMed ID: 17847104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
    Nakayama Y; Watanabe R; Murakami K; Murata K; Tanaka M; Ito H; Yamamoto W; Ebina K; Hata K; Hiramatsu Y; Katayama M; Son Y; Amuro H; Akashi K; Onishi A; Hara R; Yamamoto K; Ohmura K; Matsuda S; Morinobu A; Hashimoto M
    Rheumatol Int; 2022 Jul; 42(7):1227-1234. PubMed ID: 35266034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.
    Avila-Pedretti G; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Alperiz M; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Aterido A; López Lasanta M; Tortosa R; Julià A; Marsal S
    PLoS One; 2015; 10(4):e0122088. PubMed ID: 25848939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis.
    Robinson JI; Carr IM; Cooper DL; Rashid LH; Martin SG; Emery P; Isaacs JD; Barton A; ; Wilson AG; Barrett JH; Morgan AW
    Hum Mutat; 2012 Apr; 33(4):741-9. PubMed ID: 22290871
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Moraru M; Perez-Portilla A; Al-Akioui Sanz K; Blazquez-Moreno A; Arnaiz-Villena A; Reyburn HT; Vilches C
    Front Immunol; 2021; 12():615645. PubMed ID: 34108956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of genetic variation in the HLA-DRB1 and LTA-TNF regions on the response to treatment of early rheumatoid arthritis with methotrexate or etanercept.
    Criswell LA; Lum RF; Turner KN; Woehl B; Zhu Y; Wang J; Tiwari HK; Edberg JC; Kimberly RP; Moreland LW; Seldin MF; Bridges SL
    Arthritis Rheum; 2004 Sep; 50(9):2750-6. PubMed ID: 15457442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis.
    Graf SW; Lester S; Nossent JC; Hill CL; Proudman SM; Lee A; Rischmueller M
    Arthritis Res Ther; 2012 Feb; 14(1):R28. PubMed ID: 22309893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.
    Morris DL; Roberts AL; Witherden AS; Tarzi R; Barros P; Whittaker JC; Cook TH; Aitman TJ; Vyse TJ
    Eur J Hum Genet; 2010 Sep; 18(9):1027-31. PubMed ID: 20442749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low copy numbers of FCGR3A and FCGR3B associated with Chinese patients with SLE and AASV.
    Qi Y; Zhou X; Bu D; Hou P; Lv J; Zhang H
    Lupus; 2017 Nov; 26(13):1383-1389. PubMed ID: 28355982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the
    Márquez Pete N; Maldonado Montoro MDM; Pérez Ramírez C; Martínez Martínez F; Martínez de la Plata JE; Daddaoua A; Jiménez Morales A
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis.
    Morgan AW; Robinson JI; Barrett JH; Martin J; Walker A; Babbage SJ; Ollier WE; Gonzalez-Gay MA; Isaacs JD
    Arthritis Res Ther; 2006; 8(4):R109. PubMed ID: 16846526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.